US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Faeth Therapeutics

24.92

-1.9700-7.33%

Volume:322.64K

Turnover:8.24M

Market Cap:642.41M

PE:-0.18

High:27.03

Open:26.71

Low:23.95

Close:26.89

52wk High:42.14

52wk Low:7.45

Shares:25.78M

Float Shares:811.70K

Volume Ratio:1.06

T/O Rate:39.75%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-141.6499

EPS(LYR):-16.7239

ROE:-195.26%

ROA:-20.79%

PB:3.71

PE(LYR):-1.49

Loading ...

Overview Company News Filings

Faeth Therapeutics Initiated at Buy by Needham

Faeth Therapeutics Initiated at Buy on Oral Multi‑Node PI3K/AKT/mTOR Strategy; Analyst Sets $56 Price Target

U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions

U.S. Stocks on the MOVE - Sunrun, JetBlue Airways, Dell Technologies

Faeth Therapeutics Announces FDA Grant of Fast Track Designation for Piktor Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer

Faeth Therapeutics - Topline Data from Phase 2 Trial in Advanced Endometrial Cancer Expected by Year-End 2026

THOMSON REUTERS

Faeth Therapeutics - Interim Data from Phase 1B/2 Trial in Advanced Breast Cancer Expected in 2027

THOMSON REUTERS

Faeth Therapeutics Names Deepak Tiwari SVP of Technical Operations

Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments

THOMSON REUTERS

Faeth Therapeutics Price Target Maintained with a $60.00/Share by HC Wainwright & Co.

Faeth Therapeutics Grants New-Hire Stock Options for 11,000 Shares at $25.5 Each

Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS

Faeth Therapeutics Presents PK/PD Modeling Supporting Piktor Dose in Phase 2 Endometrial Cancer Trial FTH-PIK-201

Faeth Therapeutics management to meet with BTIG

Faeth Therapeutics, Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Faeth Therapeutics initiated with a Buy at JonesResearch

Faeth Therapeutics, Inc : Jonestrading Initiates Coverage with Buy Rating; Target Price $55

THOMSON REUTERS

Faeth Therapeutics reports Q2 EPS ($2.84) vs ($3.91) last year

Faeth Therapeutics Q2 EPS $(2.84) Beats $(3.29) Estimate

Benzinga Earnings

Faeth Therapeutics Q2 FY26 Net Loss Widens to $16.01 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/FTH/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"FTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","market":"US","secType":"STK","nameCN":"Faeth Therapeutics","latestPrice":24.92,"timestamp":1791403200000,"preClose":26.89,"halted":0,"volume":322639,"delay":0,"changeRate":-0.07326143547787277,"floatShares":811700,"shares":25778800,"eps":-141.6499,"marketStatus":"Pre-Mkt","change":-1.97,"latestTime":"10-08 04:02:32 EDT","open":26.71,"high":27.025,"low":23.95,"amount":8240670.467661999,"amplitude":0.114355,"askPrice":39.87,"askSize":200,"bidPrice":9.97,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-141.6499,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791466200000},"marketStatusCode":1,"adr":0,"listingDate":1612414800000,"exchange":"NASDAQ","adjPreClose":24.92,"postHourTrading":{"tag":"盘后","latestPrice":24.92,"preClose":24.92,"latestTime":"19:30 EDT","volume":176,"amount":4402.42,"timestamp":1791415801431,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0648763321996784},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"FTH\",,,,,undefined,":{"symbol":"FTH","floatShares":811700,"roa":"-20.79%","roe":"-195.26%","lyrEps":-16.72388,"volumeRatio":1.064876,"shares":25778800,"dividePrice":0,"high":27.025,"amplitude":0.114355,"preClose":26.89,"low":23.95,"week52Low":7.45,"pbRate":"3.71","week52High":42.1431,"institutionHeld":0,"latestPrice":24.92,"eps":-141.6499,"divideRate":0,"volume":322639,"delay":0,"ttmEps":-141.6499,"open":26.71,"prevYearClose":10.67,"prevWeekClose":28.35,"prevMonthClose":29.74,"prevQuarterClose":29.74,"fiveDayClose":29.74,"twentyDayClose":36.12,"sixtyDayClose":33.12},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/FTH\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"FTH","fiscalQuarterEnding":"2026/06","expectedEps":-1.1,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785816000000,"reportTimeType":"pre","actualEps":-2.84},{"market":"US","date":"2026-05-15","symbol":"FTH","fiscalQuarterEnding":"2026/03","expectedEps":-0.62,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-131.45},{"market":"US","date":"2026-03-30","symbol":"FTH","fiscalQuarterEnding":"2025/12","expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1774843200000,"reportTimeType":"pre","actualEps":-3.74},{"market":"US","date":"2025-11-14","symbol":"FTH","fiscalQuarterEnding":"2025/09","expectedEps":-4.11,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"pre","actualEps":-3.62},{"market":"US","date":"2025-08-05","symbol":"FTH","fiscalQuarterEnding":"2025/06","expectedEps":-6.2,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-3.91}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"FTH\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"FTH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4286,"buy":0.5714,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5714,"analysts":14,"updateTime":1789531200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/FTH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"FTH","date":"2026-10-06","current":-0.175927,"percent":0.773333,"low":-5.292894,"twenty":-4.560744,"median":-3.985108,"eighty":-3.447751,"high":-0.105707,"avg":-3.896006,"sd":1.04407,"marketCap":700275517},"quantilePoints":[{"date":"2026-06-18","current":-0.12113,"twenty":-0.118045,"median":-0.113419,"eighty":-0.108792,"marketCap":22343317},{"date":"2026-06-26","current":-3.447751,"twenty":-3.41449,"median":-0.168709,"eighty":-0.122832,"marketCap":635961861},{"date":"2026-07-02","current":-3.306599,"twenty":-3.429583,"median":-3.245107,"eighty":-0.129642,"marketCap":609925319},{"date":"2026-07-10","current":-4.547622,"twenty":-3.49387,"median":-3.330357,"eighty":-0.168709,"marketCap":838840655},{"date":"2026-07-17","current":-3.62524,"twenty":-4.398084,"median":-3.429583,"eighty":-3.196193,"marketCap":668700878},{"date":"2026-07-24","current":-3.879594,"twenty":-4.005373,"median":-3.554664,"eighty":-3.20318,"marketCap":715618211},{"date":"2026-07-31","current":-4.027734,"twenty":-4.074133,"median":-3.637119,"eighty":-3.236722,"marketCap":742943690},{"date":"2026-08-07","current":-3.227486,"twenty":-4.048697,"median":-3.62524,"eighty":-3.239088,"marketCap":631063897},{"date":"2026-08-14","current":-3.773087,"twenty":-4.030809,"median":-3.711043,"eighty":-3.239088,"marketCap":737744133},{"date":"2026-08-21","current":-4.242245,"twenty":-4.248589,"median":-3.806921,"eighty":-3.244483,"marketCap":829477642},{"date":"2026-08-28","current":-4.458983,"twenty":-4.358015,"median":-3.881185,"eighty":-3.294301,"marketCap":871855939},{"date":"2026-09-04","current":-5.154129,"twenty":-4.410264,"median":-3.939688,"eighty":-3.344613,"marketCap":1007776575},{"date":"2026-09-11","current":-5.154129,"twenty":-4.552871,"median":-3.964844,"eighty":-3.358825,"marketCap":1007776575},{"date":"2026-09-18","current":-4.642681,"twenty":-4.603777,"median":-4.03542,"eighty":-3.398343,"marketCap":907774130},{"date":"2026-09-25","current":-3.839165,"twenty":-4.572109,"median":-4.071058,"eighty":-3.426788,"marketCap":750664346},{"date":"2026-10-02","current":-3.736083,"twenty":-4.561272,"median":-4.016553,"eighty":-3.440484,"marketCap":730508814},{"date":"2026-10-06","current":-3.581459,"twenty":-4.560744,"median":-3.985108,"eighty":-3.447751,"marketCap":700275517}],"updateTime":1791426046328},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"FTH\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661426261","title":"Faeth Therapeutics Initiated at Buy by Needham","url":"https://stock-news.laohu8.com/highlight/detail?id=2661426261","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661426261?lang=en_us&edition=fundamental","pubTime":"2026-08-21 18:04","pubTimestamp":1787306640,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661261199","title":"Faeth Therapeutics Initiated at Buy on Oral Multi‑Node PI3K/AKT/mTOR Strategy; Analyst Sets $56 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2661261199","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661261199?lang=en_us&edition=fundamental","pubTime":"2026-08-21 17:55","pubTimestamp":1787306119,"startTime":"0","endTime":"0","summary":"Gil Blum, an analyst from Needham, has initiated a new Buy rating on Faeth Therapeutics (FTH). Gil Blum has given his Buy rating due to a combinati...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/faeth-therapeutics-initiated-at-buy-on-oral-multinode-pi3k-akt-mtor-strategy-analyst-sets-56-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/faeth-therapeutics-initiated-at-buy-on-oral-multinode-pi3k-akt-mtor-strategy-analyst-sets-56-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661250734","title":"U.S. Research Roundup-Health Catalyst, Nektar Therapeutics, TIC Solutions","url":"https://stock-news.laohu8.com/highlight/detail?id=2661250734","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661250734?lang=en_us&edition=fundamental","pubTime":"2026-08-21 15:26","pubTimestamp":1787297213,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Health Catalyst, Nektar Therapeutics, TIC SolutionsAug 21 (Reuters)-Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, incl","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL8N44I09H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DV","BWMN","AMP","VEGI","PI","ACEL","MCHP","ADI","COTY","AMD","MU","ABT","ADSK","MRVL","DISK","GTLB","CHAT","HL","FTH","IXN","MBX","P","BAI","QBTS","FTAI","LYTS","TRFK","HRZN","IMA","SMHX","BCAL","FERG","AMYY","DOCS","ECG","FIX","CTEV","LEGR","APP","EBS","AAP","MTSI","AVGU","EGGY","INNV","AVGO","HCAT","DE","MATW","LMB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660717436","title":"U.S. Stocks on the MOVE - Sunrun, JetBlue Airways, Dell Technologies","url":"https://stock-news.laohu8.com/highlight/detail?id=2660717436","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660717436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:52","pubTimestamp":1786981972,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE - Sunrun, JetBlue Airways, Dell TechnologiesAug 17 (Reuters)-The S&P 500 was muted on Monday as markets weighed tensions between the U.S. and Iran, while the report of a s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL6N44E0P9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SPRX","BK4602","LU2265009873.SGD","LUNL","COWG","ALAB","DT","BRBS","WSPC","SOXY","TAN","HTB","XSD","SMHX","CHAT","XTN","LU0072461881.USD","RUN","BK4588","BK4615","CNCG","FSPC","JBLU","CNC","MAIR","LU0162691827.USD","LU2362541513.USD","LUNR","IE0034235188.USD","CNAV","LABX","YSS","AIPI","BK4154","LU1506573853.SGD","WDGF","FULC","IE00BLSP4452.SGD","EYPT","ADIL","GNL","LHX","ALM","IE00BN8TJ469.HKD","LU0477156797.USD","FTH","KBR","LU0314106906.USD","LU1699723380.USD","OABI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660482872","title":"Faeth Therapeutics Announces FDA Grant of Fast Track Designation for Piktor Plus Paclitaxel in Biomarker-Selected Advanced Endometrial Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660482872","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660482872?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:31","pubTimestamp":1786966316,"startTime":"0","endTime":"0","summary":"BRIEF-Faeth Therapeutics Announces FDA Grant Of Fast Track Designation For Piktor Plus Paclitaxel In Biomarker-Selected Advanced Endometrial CancerAug 17 (Reuters)-Faeth Therapeutics, IncFTH.O:FAETH T","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUA6WSPMW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660860482","title":"Faeth Therapeutics - Topline Data from Phase 2 Trial in Advanced Endometrial Cancer Expected by Year-End 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660860482","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660860482?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:30","pubTimestamp":1786966200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUA6WSPMW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660828574","title":"Faeth Therapeutics - Interim Data from Phase 1B/2 Trial in Advanced Breast Cancer Expected in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2660828574","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660828574?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:30","pubTimestamp":1786966200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nTUA6WSPMW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659145715","title":"Faeth Therapeutics Names Deepak Tiwari SVP of Technical Operations","url":"https://stock-news.laohu8.com/highlight/detail?id=2659145715","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659145715?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:30","pubTimestamp":1786707019,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics names Deepak Tiwari SVP of technical operationsFaeth Therapeutics named Deepak Tiwari senior vice president, technical operations, to oversee CMC and supply chain for the PIKTOR pro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nNDLbDn0P0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU0211327993.USD","LU1303367103.USD","BK4082","BK4588","FTH","LU0211328371.USD","BK4139","BK4504","BAX","BK4585","LU1267930490.SGD","LU2098885051.SGD","LU0072461881.USD","LU0006061336.USD","LU0310799852.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659757145","title":"Faeth Therapeutics Strengthens Executive Team with Senior Leadership Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2659757145","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659757145?lang=en_us&edition=fundamental","pubTime":"2026-08-14 19:30","pubTimestamp":1786707000,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260814:nTUA6MLPT4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658990038","title":"Faeth Therapeutics Price Target Maintained with a $60.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2658990038","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658990038?lang=en_us&edition=fundamental","pubTime":"2026-08-11 20:27","pubTimestamp":1786451220,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/FTH/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657162573","title":"Faeth Therapeutics Grants New-Hire Stock Options for 11,000 Shares at $25.5 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2657162573","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657162573?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:00","pubTimestamp":1786132815,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics grants new-hire stock options for 11,000 shares at $25.5 eachFaeth Therapeutics granted options covering 11,000 common shares to two new employees under its 2026 Inducement Plan, ef","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL25KRQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625783","title":"Faeth Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625783","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625783?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:00","pubTimestamp":1786132800,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA2HSLQB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657485136","title":"Faeth Therapeutics Presents PK/PD Modeling Supporting Piktor Dose in Phase 2 Endometrial Cancer Trial FTH-PIK-201","url":"https://stock-news.laohu8.com/highlight/detail?id=2657485136","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657485136?lang=en_us&edition=fundamental","pubTime":"2026-08-07 19:30","pubTimestamp":1786102257,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics presents PK/PD modeling supporting PIKTOR dose in Phase 2 endometrial cancer trial FTH-PIK-201Faeth Therapeutics will present PK/PD modeling for its oral PI3K/AKT/mTOR inhibitor com","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL94wMFZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657324568","title":"Faeth Therapeutics management to meet with BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2657324568","media":"TIPRANKS","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657324568?lang=en_us&edition=fundamental","pubTime":"2026-08-05 00:25","pubTimestamp":1785860741,"startTime":"0","endTime":"0","summary":"Meeting to be held in Baltimore/Washington, DC on August 10 hosted by BTIG. Published first on TheFly – the ultimate source for real-time, market-m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-management-to-meet-with-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-management-to-meet-with-btig-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656559845","title":"Faeth Therapeutics, Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2656559845","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656559845?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:51","pubTimestamp":1785847879,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics, Inc reports results for the quarter ended June 30 - Earnings SummaryFaeth Therapeutics, IncFTH.OQreported a quarterly adjusted loss of $2.84 per share for the quarter ended June 30","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nL8N4411L9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656155535","title":"Faeth Therapeutics initiated with a Buy at JonesResearch","url":"https://stock-news.laohu8.com/highlight/detail?id=2656155535","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656155535?lang=en_us&edition=fundamental","pubTime":"2026-08-04 20:01","pubTimestamp":1785844881,"startTime":"0","endTime":"0","summary":"JonesResearch analyst Boris Peaker initiated coverage of Faeth Therapeutics (FTH) with a Buy rating and $55 price target The firm believes the comp...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-a-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-initiated-with-a-buy-at-jonesresearch-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656355387","title":"Faeth Therapeutics, Inc : Jonestrading Initiates Coverage with Buy Rating; Target Price $55","url":"https://stock-news.laohu8.com/highlight/detail?id=2656355387","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656355387?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:39","pubTimestamp":1785843559,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nFWN4410YC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656553636","title":"Faeth Therapeutics reports Q2 EPS ($2.84) vs ($3.91) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2656553636","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656553636?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:36","pubTimestamp":1785843369,"startTime":"0","endTime":"0","summary":"“Our combination with Sensei Biotherapeutics marked an important milestone in the history of Faeth Therapeutics (FTH),” said Anand Parikh, Chief Ex...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-reports-q2-eps-2-84-vs-3-91-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/faeth-therapeutics-reports-q2-eps-2-84-vs-3-91-last-year-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558027","title":"Faeth Therapeutics Q2 EPS $(2.84) Beats $(3.29) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558027","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558027?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:34","pubTimestamp":1785843269,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics (NASDAQ:FTH) reported quarterly losses of $(2.84) per share which beat the analyst consensus estimate of $(3.29) by 13.68 percent. This is a 27.37 percent increase over losses of $(3.91) per share","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/60901923/faeth-therapeutics-q2-eps-2-84-beats-3-29-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656558290","title":"Faeth Therapeutics Q2 FY26 Net Loss Widens to $16.01 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656558290","media":"Reuters","labels":["executive","dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656558290?lang=en_us&edition=fundamental","pubTime":"2026-08-04 19:30","pubTimestamp":1785843059,"startTime":"0","endTime":"0","summary":"Faeth Therapeutics Q2 FY26 net loss widens to $16.01 millionFaeth Therapeutics posted a net loss of $16.01 million, or $2.84 per share, for the quarter ended June 30, 2026.R&D expense more than double","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL2Pj33L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive,dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["FTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":2,"totalSize":94,"code":"91000000","status":"200"}]}}